These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4423376)

  • 1. Aporphines. 11. Synthesis and dopaminergic acitivity of monohydroxyaporphines. Total synthesis of (plus, minus)-11-hydroxyaporphine, (plus and minus)-11-hydroxynoraporphine, and (plus, minus)-11-hydroxy-N-n-propylnoraporphine.
    Neumeyer JL; Granchelli FE
    J Med Chem; 1974 Oct; 17(10):1090-5. PubMed ID: 4423376
    [No Abstract]   [Full Text] [Related]  

  • 2. Aporphines. 8. Total synthesis and pharmacological evaluation of (plus or minus)-apomorphine, (plus or minus)-apocodeine, (plus or minus)-N-n-propylnorapomorphine, and (plus or minus)-N-n-propylnorapocodeine.
    Neumeyer JL; Neustadt BR; Oh KH; Weinhardt KK; Boyce CB; Rosenberg FJ; Teiger DG
    J Med Chem; 1973 Nov; 16(11):1223-8. PubMed ID: 4201182
    [No Abstract]   [Full Text] [Related]  

  • 3. Aporphines, 21. (1,2) Dopaminergic activity of aporphine and benzylisoquinoline derivatives. Synthesis of 8-hydroxyaporphines and 1-(hydroxybenzyl)-2-n-propyl-1,2,3,4-tetrahydroisoquinolines.
    Costall B; Naylor RJ
    J Med Chem; 1977 Feb; 20(2):190-6. PubMed ID: 556776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral activity of some novel aporphines in rats with 6-hydroxydopamine lesions of caudate or nucleus accumbens.
    Jackson EA; Neumeyer JL; Kelly PH
    Eur J Pharmacol; 1983 Jan; 87(1):15-23. PubMed ID: 6404639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rotatory behavior induced in nigra-lesioned rats by N-propylnoraporphine, apomorphine, and levodopa.
    Mendez JS; Cotzias GC; Finn BW; Dahl K
    Life Sci; 1975 Jun; 16(11):1737-42. PubMed ID: 1143000
    [No Abstract]   [Full Text] [Related]  

  • 6. Aporphines. 14 Dopaminergic and antinociceptive activity of aporphine derivatives. Synthesis of 10-hydroxyaporphines and 10-hydroxy-N-n-propylnoraporphine.
    Neumeyer JL; Reinhard JF; Dafeldecker WP; Guarino J; Kosersky DS; Fuxe K; Agnati L
    J Med Chem; 1976 Jan; 19(1):25-9. PubMed ID: 942751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and dopamine agonist and antagonist effects of (R)-(-)- and (S)-(+)-11-hydroxy-N-n-propylnoraporphine.
    Gao Y; Zong R; Campbell A; Kula NS; Baldessarini RJ; Neumeyer JL
    J Med Chem; 1988 Jul; 31(7):1392-6. PubMed ID: 3385732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of 7-oxaaporphine derivatives and evaluation of their dopaminergic activity.
    Banzatti C; Carfagna N; Commisso R; Heidempergher F; Pegrassi L; Melloni P
    J Med Chem; 1988 Jul; 31(7):1466-71. PubMed ID: 2968456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and neuropharmacological evaluation of esters of R(-)-N-alkyl-11-hydroxy-2-methoxynoraporphines.
    Si YG; Choi YK; Gardner MP; Tarazi FI; Baldessarini RJ; Neumeyer JL
    Bioorg Med Chem Lett; 2009 Jan; 19(1):51-3. PubMed ID: 19058967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The rotational behavior model: asymmetry in the effects of unilateral 6-OHDA lesions of the substantia nigra in rats.
    Robinson TE; Becker JB
    Brain Res; 1983 Mar; 264(1):127-31. PubMed ID: 6405975
    [No Abstract]   [Full Text] [Related]  

  • 11. Aporphines. 15. Action of aporphine alkaloids on dopaminergic mechanisms in rat brain.
    Miller RJ; Kelly PH; Neumeyer JL
    Eur J Pharmacol; 1976 Jan; 35(1):77-83. PubMed ID: 943290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and dopamine receptor affinities of N-alkyl-11-hydroxy-2-methoxynoraporphines: N-alkyl substituents determine D1 versus D2 receptor selectivity.
    Si YG; Gardner MP; Tarazi FI; Baldessarini RJ; Neumeyer JL
    J Med Chem; 2008 Feb; 51(4):983-7. PubMed ID: 18251489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (R)-(-)-10-methyl-11-hydroxyaporphine: a highly selective serotonergic agonist.
    Cannon JG; Mohan P; Bojarski J; Long JP; Bhatnagar RK; Leonard PA; Flynn JR; Chatterjee TK
    J Med Chem; 1988 Feb; 31(2):313-8. PubMed ID: 3339604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in the nature of the stereotyped behaviour induced by aporphine derivatives in the rat and in their actions in extrapyramidal and mesolimbic brain areas.
    Costall B; Naylor RJ; Neumeyer JL
    Eur J Pharmacol; 1975 Mar; 31(1):1-16. PubMed ID: 1168579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further evidence for the stimulation of rat brain dopamine receptors by a cyclic analogue of dopamine.
    Woodruff GN; Elkhawad AO; Crossman AR; Walker RJ
    J Pharm Pharmacol; 1974 Sep; 26(9):740-1. PubMed ID: 4155756
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of isomers of hydroxyaporphines on dopamine metabolism in rat brain regions.
    Baldessarini RJ; Marsh ER; Kula NS; Zong RS; Gao YG; Neumeyer JL
    Biochem Pharmacol; 1990 Aug; 40(3):417-23. PubMed ID: 2383279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proceedings: Effect of aporphine alkaloids on central dopamine receptors.
    Kelly PH; Miller RJ; Neumeyer JL
    Br J Pharmacol; 1975 Jun; 54(2):271P. PubMed ID: 1148551
    [No Abstract]   [Full Text] [Related]  

  • 18. 5-HT1A-receptor antagonism: N-alkyl derivatives of (R)-(-)-8,11-dimethoxynoraporphine.
    Cannon JG; Jackson H; Long JP; Leonard P; Bhatnagar RK
    J Med Chem; 1989 Aug; 32(8):1959-62. PubMed ID: 2569041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the dopaminergic effects of N-substituted aporphines.
    Menon MK; Clark WG; Cannon JG
    J Pharm Pharmacol; 1976 Oct; 28(10):778-81. PubMed ID: 10377
    [No Abstract]   [Full Text] [Related]  

  • 20. Behavioural sequelae of dopaminergic degeneration: postsynaptic supersensitivity?
    Creese I; Iversen SD
    Psychopharmacol Bull; 1975 Oct; 11(4):12-3. PubMed ID: 1197588
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.